Novartis sues Chinese firm over attempts to make generic heart failure drug

30-09-2021

Tom Phillips

Novartis sues Chinese firm over attempts to make generic heart failure drug

Taljat David / Shutterstock.com

Pharma giant Novartis has filed a patent suit against Crystal Pharmaceuticals after the rival sought to create a generic version of its heart failure drug Entresto (sacubitril/valsartan).


Novartis, big pharma, patents, generics, heart failure, Crystal Pharmaceuticals, US District Court for the District of Delaware, Daiichi Sankyo, Regeneron

LSIPR